Evidence map›Paper›PMID 36845315›Full record

ArticleJournal of clinical and translational science2023

DEIA is essential to advance the goals of translational science: Perspectives from NCATS.

Shadab F Hussain, Amanda L Vogel, Jessica M Faupel-Badger, Linda Ho, Lameese D Akacem, Krishna Balakrishnan, Rebekah Geiger, Rashmi Gopal-Srivastava, Brittany Haynes, Marcus G Hodges and 7 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Journal of clinical and translational science · 2025
    Article
  4. Article
  5. Guidance for Addressing Conflicts, Bias, and Growth in Early Career Tobacco Regulatory Science Training Through Mentorship.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  6. Strategies to promote language inclusion at 17 CTSA hubs.Journal of clinical and translational science · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shadab F HussainNational Center for Advancing Translational Sciences, Bethesda, MD, USA.ORCID https://orcid.org/0000-0003-3837-6225
Amanda L VogelNational Center for Advancing Translational Sciences, Bethesda, MD, USA.ORCID https://orcid.org/0000-0002-2411-0736
Jessica M Faupel-BadgerNational Center for Advancing Translational Sciences, Bethesda, MD, USA.ORCID https://orcid.org/0000-0001-9729-3660
Linda HoNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Lameese D AkacemNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Krishna BalakrishnanNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Rebekah GeigerNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Rashmi Gopal-SrivastavaNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Brittany HaynesNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Marcus G HodgesNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Tanetta IslerNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Ewy A MathéNational Center for Advancing Translational Sciences, Bethesda, MD, USA.ORCID https://orcid.org/0000-0003-4491-8107
Leonie MisquittaNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Karlie R SharmaNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Eric SidNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Jamie L ZigtermanNational Center for Advancing Translational Sciences, Bethesda, MD, USA.
Penny W BurgoonNational Center for Advancing Translational Sciences, Bethesda, MD, USA.

Funding

Informatics Research CoreZICTR000410 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MATHÉ, EWY · 2021 to 2025
$11.7M
6 · The paper itself

Abstract

The National Center for Advancing Translational Science (NCATS) seeks to improve upon the translational process to advance research and treatment across all diseases and conditions and bring these interventions to all who need them. Addressing the racial/ethnic health disparities and health inequities that persist in screening, diagnosis, treatment, and health outcomes (e.g., morbidity, mortality) is central to NCATS' mission to deliver more interventions to all people more quickly. Working toward this goal will require enhancing diversity, equity, inclusion, and accessibility (DEIA) in the translational workforce and in research conducted across the translational continuum, to support health equity. This paper discusses how aspects of DEIA are integral to the mission of translational science (TS). It describes recent NIH and NCATS efforts to advance DEIA in the TS workforce and in the research we support. Additionally, NCATS is developing approaches to apply a lens of DEIA in its activities and research - with relevance to the activities of the TS community - and will elucidate these approaches through related examples of NCATS-led, partnered, and supported activities, working toward the Center's goal of bringing more treatments to all people more quickly.

Indexed as

accessibilitycommunity engagementdiversityequityhealth disparitiesinclusionTranslational scienceworkforce diversity

Identifiers

PMID36845315
PMCPMC9947606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.